Vitamin D receptor taqi gene variant in exon 9 and polycystic ovary syndrome risk

International Journal of Fertility and Sterility

Volumn 7, Issue 2, 2013, Pages 116-121

  Bagheri, Morteza ^a   Abdi Rad, Isa ^a   Hosseini Jazani, Nima ^a   Nanbakhsh, Fariba ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic variation; Polycystic ovary syndrome; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; EXON 9; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; TAQI GENE;

EID: 84881191693     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-281.
2. Farmakiotis D, Katsikis I, Panidis D. Calcium homeostasis and anovulatory infertility. Hum Reprod. 2007; 22(12): 3264.
3. Whitaker M. Calcium at fertilization and in early development. Physiol Rev. 2006; 86(1): 25-88.
4. Heaney RP. Vitamin D and calcium interactions: functional outcomes. Am J Clin Nutr. 2008; 88(2): 541S-544S.
5. Ranjzad F, Mahban A, Shemirani AI, Mahmoudi T, Vahedi M, Nikzamir A, et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet. 2011; 28(3): 225-232.
6. Elnenaei MO, Chandra R, Mangion T, Moniz C. Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation. Br J Nutr. 2011; 105(1): 71-79.
7. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999; 64(6): 430-435.
8. Urbanek M.The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007; 3(2): 103-111.
9. Holick MF. Vitamin D for health and in chronic kidney disease. Semin Dial. 2005; 18(4): 266-275.
10. Brannon PM, Picciano MF. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr. 2011; 31: 89-115.
11. Grundmann M, von Versen-Höynck F., Vitamin D-roles in women's reproductive health? Reprod Biol Endocrinol. 2011; 9: 146.
12. Liang SL, Zhao QJ, Li XC, Jin YP, Wang YP, Su XH, et al. Dynamic analysis of Ca2+ level during bovine oocytes maturation and early embryonic development. J Vet Sci. 2011; 12(2): 133-142.
13. Norman AW. Vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147(12): 5542-5548.
14. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998; 78(4): 1193-1231.
15. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC Jr, DeLisle RK. The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem. 1995; 270(9): 4748-4752.
16. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001; 81(3): 1269-1304.
17. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci USA. 1997; 94(15): 7879-7884.
18. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays. 2004; 26(1): 21-28.
19. Collingwood TN, Urnov FD, Wolffe AP. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol. 1999; 23(3): 255-275.
20. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 1997; 90(3): 569-580.
21. Hebbar PB, Archer TK. Chromatin remodeling by nuclear receptors. Chromosoma. 2003; 111(8): 495-504.
22. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2): 143-156.
23. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004; 10(16): 5472-5481.
24. Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev. 2003; 12(1): 23-27.
25. Yaylim-Eraltan I, Arzu Ergen H, Arikan S, Okay E, Oztürk O, Bayrak S, Isbir T., Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct. 2007; 25(6): 731-737.
26. Motohashi Y, Yamada S, Yanagawa T, Maruyama T, Suzuki R, Niino M, et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab. 2003; 88(7): 3137-3140.
27. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000; 49(3): 504-507.
28. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002; 51(3): 356-359.
29. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1995; 1(12): 1309-1311.
30. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA, et al. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 1998; 12(13): 1409-1417.
31. Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011; 164(5): 741-749.
32. Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril. 2009; 92(4): 1381-1383.
33. Grulet H, Hecart AC, Delemer B, Gross A, Sulmont V, Leutenegger M, et al. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf). 1993; 38(6): 621-626.
34. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012; 166(5): 765-778.
35. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19(1): 41-47.
36. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GE, Hershman SM, editors. Polycystic ovary syndrome. Current issues in endocrinology and metabolism. Boston: Blackwell; 1992; 377-384.
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
38. Asgharnia M, Mirblook F, Ahmad Soltani M. The prevalence of polycystic ovary syndrome (PCOS) in high school students in Rasht in 2009 according to NIH criteria. Int J Fertil Steril. 2011; 4(4): 156-159.
39. Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab. 2003; 14(8): 365-370.
40. Salehpour S, Taherzadeh BP, Neisani Samani E. Leptin, ghrelin, adiponectin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril. 2008;2(3):101-104.
41. Rahmanpour H, Jamal L. Metabolic abnormalities in adolescents with polycystic ovary syndrome in Zanjan-Iran. Int J Fertil Steril. 2011;5 Suppl. 1: 54.
42. Pfeifer SM. Polycystic ovary syndrome in adolescent girls. Semin Pediatr Surg. 2005; 14(2): 111-117.
43. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet. 2001; 2: 2.
44. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymor phism (FokI) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res. 1997; 12(7): 1043-1048.
45. Vigo Gago E, Cadarso-Suarez C, Perez-Fernandez R, Romero Burgos R, Devesa Mugica J, Segura Iglesias C. Association between vitamin D receptor FokI polymorphism and serum parathyroid hormone level in patients with chronic renal failure. J Endocrinol Invest. 2005; 28(2): 117-121.
46. Taylor JA, Hirvonen A,Watson M, Pittman G, Mohler JL, Bell DA., Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996; 56(18): 4108-4110.
47. Gennari L, Becherini L, Masi L, Gonnelli S, Cepollaro C, Martini S, et al. Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcif Tissue Int. 1997; 61(6): 460-463.
48. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-281.
49. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000; 141(4): 1317-3124.
50. Feldman D, Malloy PJ. Hereditary 1,25-dihydroxyvitamin D resistant rickets: molecular basis and implications for the role of 1,25(OH) 2D3 in normal physiology. Mol Cell Endocrinol. 1990; 72(3): C57-62.
51. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab, 1997; 82(12): 4111-4116.
52. Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, et al. The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod. 1995; 10(10): 2545-2549.
53. Balen AH, Tan SL, McDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod. 1993; 8(6): 959-964.
54. Gordon UD, Harrison RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril. 2001; 75(2): 324-331.
55. Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, Bernabeu R, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002; 17(4): 1017-1022.
56. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv. 2006; 61: 125-135.
57. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 1989; 31(1): 87-120.